State health leaders want 1 million vaccinations in 10 days – Orange County Register

One million vaccinations over the next 10 days.

That’s the working goal of one of California’s COVID-19 vaccination planning groups, which convened Wednesday, Jan. 6, and echoed Gov. Gavin Newsom’s desire this week to speed up the state’s mass vaccination campaign.

California currently is in the first stage – Phase 1A – of the drive, which sent a first wave of shots to hospitals and pharmacies to inoculate frontline health care workers and long-term care residents.

Phase 1A kicked off in mid-December, but has been slow going as health providers confront the logistical dilemma of redeploying staff to inject other staff in the middle of a winter rush on hospitals. There are also health care workers opting out.

Of about 2 million Pfizer-BioNTech and Moderna doses shipped to California so far, roughly 490,000 had been administered as of Tuesday, said Dr. Erica Pan, a California Department of Public Health epidemiologist and co-chair of the Community Vaccine Advisory Committee, which works with the Drafting Guidelines Workgroup to form the state’s coronavirus vaccination agenda.

“We have vaccinated a lot of people… but we do need to move faster,” Pan said. “Our goal is to administer another million in the next 10 days.”

To speed up the first leg of the race, dentists and other medical professionals are being added to the fold of personnel authorized to administer the shots. Local health departments have begun planning large-scale vaccination sites along the lines of coronavirus testing “super sites.”

It remained unclear exactly when public health officials would advise moving on to the next stage, Phase 1B, which is split into two levels.

READ  10 people in the SA tech startup sector you should follow in 2019 – Ventureburn

Tier 1 would go first and includes people age 75 and older and workers at high risk of exposure, such as teachers and workers in childcare, emergency services and food and agriculture.


Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.